Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn

[1]  K. Yung.  Localization of glutamate receptors in dorsal horn of rat spinal cord , 1998, Neuroreport.

[2]  Jianhong Luo,et al.  Subunit composition of N-methyl-D-aspartate receptors in the central nervous system that contain the NR2D subunit. , 1998, Molecular pharmacology.

[3]  K. Tan-No,et al.  Involvement of Spinal NMDA Receptors in Capsaicin-Induced Nociception , 1998, Pharmacology Biochemistry and Behavior.

[4]  K Naujoks,et al.  Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. , 1997, Brain research. Molecular brain research.

[5]  F. Menniti,et al.  Antinociceptive activity of CP‐101,606, an NMDA receptor NR2B subunit antagonist , 1997, British journal of pharmacology.

[6]  F. Menniti,et al.  CP-101,606, a potent neuroprotectant selective for forebrain neurons. , 1997, European journal of pharmacology.

[7]  A. Basbaum,et al.  NMDA-receptor regulation of substance P release from primary afferent nociceptors , 1997, Nature.

[8]  J. Hunter,et al.  The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. , 1997, European journal of pharmacology.

[9]  J. Kemp,et al.  A novel mechanism of activity‐dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. , 1996, The Journal of physiology.

[10]  P. Leeson,et al.  Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex. , 1996, The Journal of pharmacology and experimental therapeutics.

[11]  C. Ragan,et al.  Modulation of 45Ca2+ Influx into Cells Stably Expressing Recombinant Human NMDA Receptors by Ligands Acting at Distinct Recognition Sites , 1996, Journal of neurochemistry.

[12]  R. Hargreaves,et al.  Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation‐induced mechanical hyperalgesia in rats , 1996, British journal of pharmacology.

[13]  G. Rordorf,et al.  Gabapentin as a novel treatment for postherpetic neuralgia , 1996, Neurology.

[14]  J. Gilmore,et al.  The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia. , 1996, European journal of pharmacology.

[15]  A. Wenzel,et al.  Distribution of NMDA receptor subunit proteins NR2A, 2B, 2C and 2D in rat brain , 1995, Neuroreport.

[16]  P. Ferroli,et al.  Lamotrigine control of idiopathic trigeminal neuralgia. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[17]  J Kerby,et al.  Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. , 1995, Molecular pharmacology.

[18]  C. R. Goucke,et al.  Acute Phantom Limb Pain Controlled by Ketamine , 1995, Anaesthesia and intensive care.

[19]  M. Collins,et al.  (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses. , 1995, Journal of medicinal chemistry.

[20]  S J Kish,et al.  Polyamines in Human Brain: Regional Distribution and Influence of Aging , 1995, Journal of neurochemistry.

[21]  M. Byas-Smith,et al.  Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. , 1995, Clinical neuropharmacology.

[22]  P. Eide,et al.  Continuous subcutaneous administration of the N-methyl-d-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia , 1995, Pain.

[23]  S. Boyce,et al.  L-745,337: A selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats , 1994, Neuropharmacology.

[24]  P. Malherbe,et al.  Alternatively spliced isoforms of the N-methyl-d-aspartate receptor subunit 1 are differentially distributed within the rat spinal cord , 1994, Neuroscience.

[25]  D. Price,et al.  The N-methyl-d-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man , 1994, Pain.

[26]  P. Leeson,et al.  The anticonvulsant and behavioural profile of L‐687,414, a partial agonist acting at the glycine modulatory site on the N‐methyl‐D‐aspartate (NMDA) receptor complex , 1994, British journal of pharmacology.

[27]  Y. Jan,et al.  Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Seeburg,et al.  The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  K Williams,et al.  Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. , 1993, Molecular pharmacology.

[30]  D. Price,et al.  Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy , 1993, Brain Research.

[31]  K. Moriyoshi,et al.  Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. , 1993, The Journal of biological chemistry.

[32]  T. Gordh,et al.  The NMDA-receptor antagonist CPP abolishes neurogenic ‘wind-up pain’ after intrathecal administration in humans , 1992, Pain.

[33]  James N. Campbell,et al.  Peripheral and central mechanisms of cutaneous hyperalgesia , 1992, Progress in Neurobiology.

[34]  R. Dubner,et al.  Association of pain relief with drug side effects in postherpetic neuralgia: A single‐dose study of clonidine, codeine, ibuprofen, and placebo , 1988, Clinical pharmacology and therapeutics.

[35]  B. Meyerson,et al.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain , 1988, Pain.

[36]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[37]  M. Zimmermann,et al.  Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.

[38]  S. Ferreira,et al.  Central and peripheral antialgesic action of aspirin-like drugs. , 1978, European journal of pharmacology.